Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,866 GBX | -.--% | -.--% | +0.21% |
Jan. 17 | Stocks slump as Fed rate cut hope dwindles | AN |
Jan. 17 | Dechra Pharmaceuticals Delists From London Bourse Following Freya Bidco’s Takeover | MT |
Sales 2022 | 682M 861M | Sales 2023 | 762M 962M | Capitalization | 4.2B 5.3B |
---|---|---|---|---|---|
Net income 2022 | 58M 73.26M | Net income 2023 | -27M -34.1M | EV / Sales 2022 | 5.8 x |
Net Debt 2022 | 208M 263M | Net Debt 2023 | 430M 543M | EV / Sales 2023 | 6.08 x |
P/E ratio 2022 |
64.8
x | P/E ratio 2023 |
-150
x | Employees | - |
Yield 2022 |
1.3% | Yield 2023 |
0.34% | Free-Float | 0% |
3 months | +0.21% | ||
6 months | +1.84% | ||
Current year | +0.21% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Page
CEO | Chief Executive Officer | 63 | 97-06-12 |
Paul Sandland
DFI | Director of Finance/CFO | 44 | 09-12-31 |
Jamie Adams
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Page
CEO | Chief Executive Officer | 63 | 97-06-12 |
Geeta Gopalan
BRD | Director/Board Member | 59 | 22-12-31 |
Alison Platt
CHM | Chairman | - | 20-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.11% | 1 M€ | -.--% | ||
0.08% | 735 M€ | -.--% | - |